Sportschule FFb Puch GmbH
Fürstenfeldbruck, 82256, Germany
NCT Number: NCT01845558
The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.
Looking for future studies?
Notify Me20 year–50 year
Male
Interventional
Phase 4
Fürstenfeldbruck, 82256, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: immediately before, 24h post, 48h post
Multidimensional approach for recovery and acute phase after eccentric stress test. Will be assessed at different time points before and after an excentric stress test and the reduction of these parameters under treatment will be calculated.
Time frame: immediately before, 0h, 3h, 6h, 24h, 48h, 72h
Reduction of strength induced by the excentric stress test
Time frame: immediately before, 0h, 3h, 6h, 24h, 48h, 72h
Pain induced by the stress test rated via Algometry kg/cm*cm induced by standardised pressure
Time frame: immediately before, 0h, 3h, 6h, 24h, 48h, 72h
Blood routine parameters (differentiated haemogram; blood lipids; glucose; kreatinin) as safety parameters
Time frame: immediately before, 24h, 48h, 72h
Blood pressure and heart rate as safety parameter
Time frame: immediately before, 0h, 3h, 6h, 24h, 48h, 72h post
Pain induced by a standardised movement and rated by the volunteer via VAS.
Mucos Pharma GmbH & Co. KG
Industry
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise - a Randomized, Two-stage, Double-blind, Placebo-controlled Cross-over Trial
Acronym: 2012-005003-40
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04742244
Muscle Injury, Muscle Soreness
Taoyuan, Taiwan
View Trial DetailsNCT03660969
Atrophy, Muscle Atrophy
Innsbruck, Austria
View Trial DetailsNCT01940627
Behavior, Inflammation
Granada, Spain
View Trial DetailsNCT06713200
Fibrosis, Muscle Injury
Salamanca, Spain
View Trial Details